Actinium Pharmaceuticals, Inc. - FORM 10-K - EX-23.1 - CONSENT OF GBH CPAS, PC - March 16, 2017

Attached files

file filename
EX-10.60 - AMENDMENT TO EMPLOYMENT AGREEMENT - DRAGAN CICIC - Actinium Pharmaceuticals, Inc.f10k2016ex10lx_actinium.htm
10-K - ANNUAL REPORT - Actinium Pharmaceuticals, Inc.f10k2016_actiniumpharma.htm
EX-32.2 - CERTIFICATION - Actinium Pharmaceuticals, Inc.f10k2016ex32ii_actinium.htm
EX-32.1 - CERTIFICATION - Actinium Pharmaceuticals, Inc.f10k2016ex32i_actinium.htm
EX-31.2 - CERTIFICATION - Actinium Pharmaceuticals, Inc.f10k2016ex31ii_actinium.htm
EX-31.1 - CERTIFICATION - Actinium Pharmaceuticals, Inc.f10k2016ex31i_actinium.htm
EX-10.66 - INDEMNIFICATION AGREEMENT - MARK S. BERGER - Actinium Pharmaceuticals, Inc.f10k2016ex10lxvi_actinium.htm
EX-10.65 - CONFIDENTIAL INFORMATION AND INVENTION ASSIGNMENT AGREEMENT - Actinium Pharmaceuticals, Inc.f10k2016ex10lxv_actinium.htm
EX-10.64 - OFFER LETTER - DR. MARK S. BERGER - Actinium Pharmaceuticals, Inc.f10k2016ex10lxiv_actinium.htm
EX-10.63 - WARRANT TO PURCHASE COMMON STOCK OF ACTINIUM PHARMACEUTICALS, INC., DATED MARCH - Actinium Pharmaceuticals, Inc.f10k2016ex10lxiii_actinium.htm
EX-10.62 - AMENDMENT TO ACTINIUM PHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCK, DA - Actinium Pharmaceuticals, Inc.f10k2016ex10lxii_actinium.htm
EX-10.61 - AMENDMENT TO ACTINIUM PHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCK, DA - Actinium Pharmaceuticals, Inc.f10k2016ex10lxi_actinium.htm
EX-10.59 - FIFTH AMENDMENT TO THE 2013 AMENDED AND RESTATED STOCK PLAN - Actinium Pharmaceuticals, Inc.f10k2016ex10lix_actinium.htm

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in the Registration Statement on Form S-3 (File No. 333-194768) and Form S-8 (File No. 333-197283) filed with the Securities and Exchange Commission, of our report dated March 16, 2017, relating to the consolidated financial statements of Actinium Pharmaceuticals, Inc. as of December 31, 2016 and 2015 and for each of the three years ended December 31, 2016 and relating to the internal controls over financial reporting for the year ended December 31, 2016, appearing in this Annual Report on Form 10-K of Actinium Pharmaceuticals, Inc.

 

/s/ GBH CPAs, PC

 

GBH CPAs, PC

www.gbhcpas.com

Houston, Texas

 

March 16, 2017

Actinium Pharmaceuticals, Inc. Reports